EP0731705B1 - Verwendung von dimeticon zur behandlung der konstipation - Google Patents

Verwendung von dimeticon zur behandlung der konstipation Download PDF

Info

Publication number
EP0731705B1
EP0731705B1 EP95903316A EP95903316A EP0731705B1 EP 0731705 B1 EP0731705 B1 EP 0731705B1 EP 95903316 A EP95903316 A EP 95903316A EP 95903316 A EP95903316 A EP 95903316A EP 0731705 B1 EP0731705 B1 EP 0731705B1
Authority
EP
European Patent Office
Prior art keywords
dimeticone
constipation
dimethylpolysiloxane
treating constipation
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
EP95903316A
Other languages
English (en)
French (fr)
Other versions
EP0731705A1 (de
Inventor
Alfred Schmidt
Hans-Jürgen Upmeyer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Schmidt Alfred
UPMEYER, HANS-JUERGEN
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of EP0731705A1 publication Critical patent/EP0731705A1/de
Application granted granted Critical
Publication of EP0731705B1 publication Critical patent/EP0731705B1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives

Definitions

  • Constipation means a delay in the discharge of dry and hard feces. It is caused either by a delayed passage of the stomach contents through the intestine or a disorder of the evacuation reflex. Possible reasons for the delayed passage through the intestine are dietetic factors, changes in the intestinal walls or a functional or organic disorder of the nervous system. Also, pharmaceuticals may have a constipating effect. A defect in the defecation mechanism is found in disorders of the anal channel, in the case of loss of the rectal dilation reflex or a weakness in the abdominal muscles used to apply abdominal pressure. Patients complain about symptoms such as a sensation of pressure, flatulence, and pains during the discharge of feces.
  • Constipation is treated with laxatives which on the one hand soften the hard feces and on the other hand prompt defecation.
  • Laxatives either act as lubricants, fillers or swelling agents, have saline or osmotic properties, or produce an anti-absorptive or secretagogue effect.
  • the substances of the afore-mentioned groups are combined in commercial preparations in many ways.
  • dimethylpolysiloxane (dimeticone) was found to be effective in the treatment of constipation, without producing the usual side effects.
  • dimeticone-containing preparations are used to treat indications such as flatulence, sensation of repletion (bloating) and meteorism. Moreover, the use of dimeticone for treating inflammatory and ulcerous diseases of the esophagus, the stomach and the duodenum has been described.
  • compositions or therapeutic regimens for the treatment of constipation comprise in addition to a conventional laxative component either dimeticone or simethicone based on their deflatulent properties.
  • Dimethylpolysiloxane may be administered to a human or animal in the form of tablets, capsules, emulsions, suspensions and powders for oral administration or in combination with foodstuffs and dietary supplements. Such compositions may be administered to humans and animals in a safe and effective amount to elicit the desired result.
  • the compositions used for this invention typically comprise an effective amount of dimethylpolysiloxane and a biologically acceptable carrier.
  • Such carriers may be solid or liquid, such as, for example, highly dispersed silicon dioxide, cornstarch, lactose, saccharose, glucose, sucrose, water, water and fat emulsions such as glycerin stearate emulsions and flavoring agents.
  • the dosage forms may be tablets, capsules or lozenges.
  • Liquid dosage forms include soft gelatine capsules, syrup or liquid suspension.
  • the dimeticone-containing compositions may be employed according to this invention in a conventional manner for the treatment and prevention of constipation. Their dosage levels may be chosen by those of ordinary skill in the art from the available methods and techniques. Specific dosage and treatment regimens will depend upon factors such as health status and the severity and course of constipation and disposition thereto.
  • composition could now be finely dosed, admixed with an inert tabletting mass consisting of saccharose, glucose, lactose and flavoring agents, and made into tablets. It is also possible to dilute the resulting mass with water to prepare a liquid preparation for administration as drops.
  • treatment composition sex female age 2 years diagnosis constipation additional symptoms tibia fracture (left side) resulting in a bed-ridden condition duration of constipation three days concomitant symptoms non-specific symptomatic pains therapy one teaspoon of the dimeticone suspension result complete evacuation of the feces (bowels) after two hours

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Claims (5)

  1. Verwendung von Dimethylpolysiloxan als einzigen abführend wirkenden Inhaltsstoff zur Herstellung eines Arzneimittels zur Behandlung von Verstopfung.
  2. Verwendung nach Anspruch 1, wobei Dimethylpolysiloxan in Kombination mit hochdispergiertem Silicumdioxid verwendet wird.
  3. Verwendung nach einem der Ansprüche 1 oder 2, wobei Dimethylpolysiloxan in Kombination mit einem biologisch verträglichen Emulgator verwendet wird.
  4. Verwendung nach Anspruch 3, wobei der Emulgator Glycerinstearat ist.
  5. Verwendung nach einem der Ansprüche 1 bis 4 zur Behandlung von Verstopfung bei einem Kind, einem bewegungsunfähigen oder alten Patienten oder einer schwangeren Frau.
EP95903316A 1993-12-02 1994-12-02 Verwendung von dimeticon zur behandlung der konstipation Expired - Lifetime EP0731705B1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4341165 1993-12-02
DE4341165A DE4341165C1 (de) 1993-12-02 1993-12-02 Verwendung von Dimeticon zur Behandlung von Obstipation
PCT/EP1994/004024 WO1995015170A1 (en) 1993-12-02 1994-12-02 Use of dimeticone for treating constipation

Publications (2)

Publication Number Publication Date
EP0731705A1 EP0731705A1 (de) 1996-09-18
EP0731705B1 true EP0731705B1 (de) 2001-11-07

Family

ID=6504057

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95903316A Expired - Lifetime EP0731705B1 (de) 1993-12-02 1994-12-02 Verwendung von dimeticon zur behandlung der konstipation

Country Status (21)

Country Link
EP (1) EP0731705B1 (de)
JP (1) JP4047376B2 (de)
CN (1) CN1138296A (de)
AT (1) ATE208202T1 (de)
AU (1) AU1242095A (de)
BG (1) BG100686A (de)
CZ (1) CZ286371B6 (de)
DE (2) DE4341165C1 (de)
HU (1) HU216837B (de)
IL (1) IL111804A (de)
LT (1) LT4123B (de)
LV (1) LV11593B (de)
MD (1) MD1484F2 (de)
NO (1) NO962221L (de)
NZ (1) NZ277255A (de)
PL (1) PL314799A1 (de)
RU (1) RU2143907C1 (de)
SI (1) SI9420073A (de)
SK (1) SK70296A3 (de)
WO (1) WO1995015170A1 (de)
ZA (1) ZA949564B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY138097A (en) * 2000-03-22 2009-04-30 Du Pont Insecticidal anthranilamides
KR100442174B1 (ko) * 2001-09-25 2004-07-30 (주)다산메디켐 이산화규소, 폴리소르베이트류 및디메칠폴리실록산(디메치콘, 시메치콘)을 함유하는소화기장애에 사용되는 고형의 신규의약조성물
RU2384339C2 (ru) * 2004-04-13 2010-03-20 Бёрингер Ингельхайм Интернациональ Гмбх Применение симетикона для предрасположенных к запорам пациентов
DE102006001199A1 (de) * 2006-01-10 2007-07-12 Medicoforum Gmbh Fixe Kombination von Substanzen unter Beigabe von Entschäumern zum Einsatz als Darmspüllösung und/oder Laxans
DE102012024434A1 (de) 2012-12-14 2014-06-18 Regalismons S.A. Verstärkung der entschäumenden Wirkung von Polysiloxanen, zugehöriger Zusammensetzungen und Lösungen
IT202000001831A1 (it) * 2020-01-30 2021-07-30 Caprika Srl Composizione per applicazione rettale a base di sale di acido butirrico per il trattamento delle patologie proctologiche

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5549M (de) * 1966-04-14 1967-11-20
FR2438431A1 (fr) * 1978-10-09 1980-05-09 Grimberg Georges Produits speciaux et compositions pharmaceutiques a base de son pour dispersions
DE3807712A1 (de) * 1987-07-25 1989-02-02 Nordend Apotheke Angela Hein Arzneimittel-trockenpraeparat zur bereitung einer laxativ wirkenden trinkloesung sowie ein verfahren zur herstellung dieses praeparates
UA15913A (uk) * 1989-01-19 1997-06-30 Штайгервальд Арцнайміттельверк Гмбх Засіб для лікуваhhя запальhих захворюваhь стравоходу та запальhих виразкових захворювань шлуhково-кишкового тракту

Also Published As

Publication number Publication date
MD1484F2 (ro) 2000-06-30
CZ157996A3 (en) 1997-01-15
WO1995015170A1 (en) 1995-06-08
AU1242095A (en) 1995-06-19
NO962221L (no) 1996-06-14
HUT75529A (en) 1997-05-28
IL111804A (en) 2001-06-14
BG100686A (en) 1997-01-31
RU2143907C1 (ru) 2000-01-10
NO962221D0 (no) 1996-05-30
LT96094A (en) 1996-12-27
PL314799A1 (en) 1996-09-30
LV11593B (en) 1997-04-20
LT4123B (en) 1997-03-25
HU216837B (hu) 1999-09-28
LV11593A (lv) 1996-12-20
CN1138296A (zh) 1996-12-18
SK70296A3 (en) 1997-06-04
HU9601498D0 (en) 1996-07-29
IL111804A0 (en) 1995-01-24
SI9420073A (en) 1997-02-28
CZ286371B6 (cs) 2000-03-15
DE69429013D1 (de) 2001-12-13
NZ277255A (en) 1999-09-29
ATE208202T1 (de) 2001-11-15
DE4341165C1 (de) 1995-04-20
EP0731705A1 (de) 1996-09-18
JPH09505824A (ja) 1997-06-10
ZA949564B (en) 1995-08-16
JP4047376B2 (ja) 2008-02-13

Similar Documents

Publication Publication Date Title
US4225596A (en) Method for treating calcium imbalance and improving calcium absorption in mammals
EP0428296B1 (de) Pharmazeutische Zusammensetzungen zur Behandlung gastrointestinaler Störungen
US5418220A (en) Method for treating constipation using dimethicone
US5182112A (en) Antidiarrheal compositions containing laperamide hydrochloride and a saccharide
AU623197B2 (en) N-acetyl glucosamine as a cytoprotective agent
EP0731705B1 (de) Verwendung von dimeticon zur behandlung der konstipation
CA2177955C (en) Use of dimeticone for treating constipation
Gryboski et al. Bismuth subsalicylate in the treatment of chronic diarrhea of childhood.
Abt et al. Influence of catharsis and diarrhea on gastrointestinal absorption of ascorbic acid in infants
JPS6163618A (ja) 下剤
WO2003000299A1 (en) Laxative preparation
RU2192867C2 (ru) Способ лечения язвенной болезни желудка и двенадцатиперстной кишки
JPH0122A (ja) 低カルシウム血症及び骨代謝異常症の予防・治療剤
Stebbins et al. Clinical use of cholestyramine resin in diarrheas of various etiology
Anand et al. Comparative assessment of phenolphthalein and phenolphthalein glucuronide: is phenolphthalein glucuronide a better laxative?
AU2002312652A1 (en) Laxative preparation
Acid justify our having recourse to the following operations: For
Hewlett Fetal mortality 100%
Turner et al. Approved Names
Abortifacient et al. Medical Glossary
Orr The Dyspepsias of Southern India
Turner et al. Approved Names
Smook, CH and Swanson Treatment of constipation: Part 2
Bush Potters̕ Compend of Materia Medica Therapeutics and Prescription Writing: With Especial Reference to the Physiological Actions of Drugs Based on the Ninth Revision of the US Pharmacopoeia, Including Also Many Unofficial Remedies

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19960627

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 19990322

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: UPMEYER, HANS-JUERGEN

Owner name: SCHMIDT, ALFRED

RIN1 Information on inventor provided before grant (corrected)

Inventor name: UPMEYER, HANS-JUERGEN

Inventor name: SCHMIDT, ALFRED

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20011107

Ref country code: LI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20011107

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRE;WARNING: LAPSES OF ITALIAN PATENTS WITH EFFECTIVE DATE BEFORE 2007 MAY HAVE OCCURRED AT ANY TIME BEFORE 2007. THE CORRECT EFFECTIVE DATE MAY BE DIFFERENT FROM THE ONE RECORDED.SCRIBED TIME-LIMIT

Effective date: 20011107

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20011107

Ref country code: FR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20011107

Ref country code: CH

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20011107

Ref country code: BE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20011107

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20011107

REF Corresponds to:

Ref document number: 208202

Country of ref document: AT

Date of ref document: 20011115

Kind code of ref document: T

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20011202

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20011202

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20011203

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REF Corresponds to:

Ref document number: 69429013

Country of ref document: DE

Date of ref document: 20011213

REG Reference to a national code

Ref country code: GB

Ref legal event code: IF02

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20020207

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20020207

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20020207

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20020207

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20020208

NLV1 Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents act
REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20020530

EN Fr: translation not filed
PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20020207

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

26N No opposition filed